Cite
HARVARD Citation
Lambertini, M. et al. (2019). Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients. Journal of the National Cancer Institute. pp. 86-94. [Online].